Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Declines By 30.6%

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totaling 10,980 shares, a decrease of 30.6% from the November 30th total of 15,827 shares. Based on an average trading volume of 9,632 shares, the short-interest ratio is presently 1.1 days. Based on an average trading volume of 9,632 shares, the short-interest ratio is presently 1.1 days.

Alpha Tau Medical Stock Performance

Alpha Tau Medical stock traded down $0.11 during mid-day trading on Monday, reaching $0.21. The company’s stock had a trading volume of 1,115 shares, compared to its average volume of 16,629. Alpha Tau Medical has a twelve month low of $0.13 and a twelve month high of $0.50. The business has a 50 day moving average price of $0.32 and a 200-day moving average price of $0.30.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.